CELLXTRACT provides high levels of cells and their associated signals to deliver optimum clinical results.

The CELLXTRACT Difference

• Independently reviewed clinical data shows the number of stem cells collected by CELLXTRACT, as counted by fibroblast-like colony-forming units (CFU-f), are greater than aspirations from a standard needle of similar volumes and is comparable or greater than final products after centrifugation.⁵
• Autologous bone marrow aspirate (BMA) contains the needed cells and growth factors to enhance bone healing.
• There is no waste of biologic material or discard of viable cells compared to inherent inefficiencies in centrifuge-based systems.

.

Economics

• Potential savings can be realized as compared to the centrifuge-based competitors. Generally, the cost of CELLXTRACT is less than the disposable kit associated with those systems.
• No additional personnel is needed to operate equipment as no centrifugation is required.

Safety

• The aspirated fluid is not required to leave the sterile field for centrifugation, creating less risk for contamination or infection.
• Traditional needles require repositioning via an additional insertion point(s) or angling in order to access a fresh channel of BMA increasing the risk of infection, blood loss, and operative time. CELLXTRACT, on the other hand, only requires one insertion point minimizing the risks to the patient.